Imaging in Neuro-oncology
Seminars in Neurology · 01.12.2025 · 45 (06) · 654-665
DOI: 10.1055/a-2719-5058 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Neurology, erschienen am 01.12.2025. Verfasst von Elizabeth Coffee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, United States. Hauptthemen laut MEDLINE: Brain Neoplasms, Neuroimaging, Glioma, Meningioma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Brain tumors are a diverse group of neoplasms that vary widely in treatment and prognosis. Imaging serves as the cornerstone of diagnosis, monitoring response to treatment and identifying progression of disease in neuro-oncologic care. This review outlines current and emerging imaging modalities with a focus on clinical application in glioma, meningioma, and brain metastasis. We cover standard imaging modalities, advanced magnetic resonance techniques such as perfusion and spectroscopic imaging, and nuclear imaging with positron emission tomography (PET), including amino acid PET. We summarize the standardized Response Assessment in Neuro-Oncology (RANO) criteria, and explore innovations in radiomics, artificial intelligence, and targeted imaging biomarkers. Finally, we address challenges related to equitable access to advanced imaging. This review provides a practical, clinically focused guide to support neurologists in the imaging-based care of patients with primary or metastatic brain tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
- Department of Neurology, Weill Cornell Medicine, New York, New York, United States.
- Immigrant and Cancer Disparities Service, Department of Psychiatry, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
ORCID-Profile: Joshua A Budhu
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Coffee, E., Elshiekh, C., & Budhu, J. A. (2025). Imaging in Neuro-oncology. Seminars in Neurology, 45(06), 654-665. https://doi.org/10.1055/a-2719-5058
Vancouver
Coffee E, Elshiekh C, Budhu JA. Imaging in Neuro-oncology. Seminars in Neurology. 2025;45(06):654-665. doi:10.1055/a-2719-5058
BibTeX
@article{Coffee2025,
author = {Coffee, Elizabeth and Elshiekh, Cleopatra and Budhu, Joshua A},
title = {Imaging in Neuro-oncology},
journal = {Seminars in Neurology},
year = {2025},
volume = {45},
number = {06},
pages = {654--665},
doi = {10.1055/a-2719-5058}
}
EUVIMED